Neuroprotective Properties of Food-Borne Polyphenols in Neurodegenerative Diseases

Código QR

Neuroprotective Properties of Food-Borne Polyphenols in Neurodegenerative Diseases

Fruits and vegetables are the richest source of polyphenols in the regular human diet [...]

Guardado en:

Detalles Bibliográficos
Autores principales:	Rui F. M. Silva, Lea Pogačnik
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	n/a Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/2f4d591c24a549508c82c015a5cf70e3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Potential of Dietary Antioxidants
por: Irene Dini
Publicado: (2021)

Antibiotics in Orthopedic Infections
por: Konstantinos Anagnostakos, et al.
Publicado: (2021)

Dietary Antioxidants and Brain Health: Focus on Cognitive and Affective Disorders
por: Justyna Godos, et al.
Publicado: (2021)

Editorial on Anticancer Antioxidants
por: Suzana Borovic Sunjic, et al.
Publicado: (2021)

Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units
por: Séverine Martin-Mons, et al.
Publicado: (2021)

Neuroprotective Effects of Berry on Neurobehavioral Changes and Neuronal Loss in the Hippocampus of Mice Exposed to Acute Ionizing Radiation
por: Lei Guo, et al.
Publicado: (2021)

Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma
por: Luigi Manni, et al.
Publicado: (2021)

Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers
por: Farr SJ, et al.
Publicado: (2015)

Pharmacological properties of selenium and its preparations: from antioxidant to neuroprotector
por: Igor F. Belenichev, et al.
Publicado: (2021)

Prostacyclin mediates endothelial COX-2-dependent neuroprotective effects during excitotoxic brain injury
por: An Y, et al.
Publicado: (2014)

Therapeutic Effects and Safe Uses of Plant-Derived Polyphenolic Compounds in Cardiovascular Diseases: A Review
por: Alotaibi BS, et al.
Publicado: (2021)

Parkinson's disease: carbidopa, nausea, and dyskinesia
por: Hinz M, et al.
Publicado: (2014)

Treatment of Cushing disease: overview and recent findings
por: Tatiana Mancini, et al.
Publicado: (2010)

An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)
por: Wollenberg LA, et al.
Publicado: (2015)

The Parkinson's disease death rate: carbidopa and vitamin B6
por: Hinz M, et al.
Publicado: (2014)

Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility
por: Flora T. Musuamba, et al.
Publicado: (2021)

Immunomodulation induced by central nervous system‐related peptides as a therapeutic strategy for neurodegenerative disorders
por: María Laura Palumbo, et al.
Publicado: (2021)

Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization
por: Kose E, et al.
Publicado: (2014)

Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor
por: Davis EM, et al.
Publicado: (2013)

The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
por: Ying Cao, et al.
Publicado: (2021)

N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models
por: Lanzhou Li, et al.
Publicado: (2019)

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
por: Aguirre Valadez J, et al.
Publicado: (2015)

Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition: the EU-EFFICHRONIC project
por: Sabrina Zora, et al.
Publicado: (2021)

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein&ndash;Barr virus disease
por: Heather&nbsp;E Vezina, et al.
Publicado: (2009)

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients
por: Stefan Willmann, et al.
Publicado: (2021)

Impact of polyphenols in phagocyte functions
por: da Cunha LR, et al.
Publicado: (2019)

Changes in Browning Degree and Reducibility of Polyphenols during Autoxidation and Enzymatic Oxidation
por: Xuan Zhou, et al.
Publicado: (2021)

The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
por: Anna Nowak, et al.
Publicado: (2021)

Symptomatic flexible flatfoot in adults: subtalar arthroereisis
por: Ozan F, et al.
Publicado: (2015)

Characteristics of the Polyphenolic Profile and Antioxidant Activity of Cone Extracts from Conifers Determined Using Electrochemical and Spectrophotometric Methods
por: Malgorzata Latos-Brozio, et al.
Publicado: (2021)

Corrigendum to “Potential use of extract of the plant Schwartiza brasiliensis (choisy) bedell exgir.-Cañas against the toxic effects of the venom of Bothrops jararaca or B. jararacussu” [Biomed. Pharmacother. 125 (2020) 109951]
por: Jenifer Frouche de Souza, et al.
Publicado: (2021)

The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
por: Thiago M. C. Pereira, et al.
Publicado: (2021)

In Reference to Risk Perception of Septic Shock with Multiple Organ Failure Due to Acute Exacerbation of an Infectious Dental Disease [Letter]
por: Baba Y, et al.
Publicado: (2021)

Distribution and Resistance of Pathogens in Liver Transplant Recipients with Acinetobacter baumannii Infection [Expression of Concern] [Erratum]
por: Gao F, et al.
Publicado: (2020)

NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines
por: North WG, et al.
Publicado: (2015)

Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes
por: Di Pierro F, et al.
Publicado: (2013)

Erratum
por: Barrese V, et al.
Publicado: (2012)

Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin
por: Tjandrawinata RR, et al.
Publicado: (2015)

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
por: Frost C, et al.
Publicado: (2018)

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
por: Frost C, et al.
Publicado: (2014)